Departments of Radiation Oncology.
Departments of Radiation Oncology.
Int J Radiat Oncol Biol Phys. 2024 Oct 1;120(2):482-495. doi: 10.1016/j.ijrobp.2024.03.031. Epub 2024 Apr 2.
Postmastectomy radiation therapy is a mainstay in the adjuvant treatment of node-positive breast cancer, but it poses risks for women with breast reconstruction. Multibeam intensity-modulated radiation therapy improves dose conformality and homogeneity, potentially reducing complications in breast cancer patients with implant-based reconstruction. To investigate this hypothesis, we conducted a single-arm phase 2 clinical trial of breast cancer patients who underwent mastectomy/axillary dissection and prosthesis-based reconstruction.
The primary endpoint was the rate of implant failure (IF) within 24 months of permanent implant placement, which would be considered an improvement over historical controls if below 16%. IF was defined as removal leading to a flat chest wall or replacement with another reconstruction. Patients were analyzed in 2 cohorts. Cohort 1 (RT-PI) received radiation therapy to the permanent implant. Cohort 2 (RT-TE) received radiation therapy to the TE. IF rates, adverse events, and quality of life were analyzed. Follow-up/postradiation therapy assessments were compared with the baseline/preradiation therapy assessments at 3 to 10 weeks after exchange surgery. A subgroup underwent serial magnetic resonance imaging (MRI) sessions to explore the association between MRI-detected changes and capsular contracture, a known adverse effect of radiation therapy.
Between June 2014 and March 2017, 119 women were enrolled. Cohort 1 included 45 patients, and cohort 2 had 74 patients. Among 100 evaluable participants, 25 experienced IF during the study period. IF occurred in 8/42 (19%) and 17/58 (29%) in cohorts 1 and 2, respectively. Among the IFs, the majority were due to capsular contracture (13), infection (7), exposure (3), and other reasons (2). Morphologic shape features observed in longitudinal MRI images were associated with the development of Baker grade 3 to 4 contractures.
The rate of IF in reconstructed breast cancer patients treated with intensity-modulated radiation therapy was similar to, but not improved over, that observed with conventional, 3-dimensional-conformal methods. MRI features show promise for predicting capsular contracture but require validation in larger studies.
术后放疗是淋巴结阳性乳腺癌辅助治疗的主要手段,但它会给接受乳房重建的女性带来风险。多束强度调制放疗提高了剂量适形性和均匀性,有可能降低乳腺癌患者接受基于植入物重建的并发症。为了验证这一假设,我们对接受乳房切除术/腋窝清扫术和假体重建的乳腺癌患者进行了单臂 2 期临床试验。
主要终点是永久性植入物放置后 24 个月内的植入物失败(IF)率,如果低于 16%,则认为优于历史对照。IF 定义为导致平胸壁或用另一种重建物替换的移除。患者分为 2 组。队列 1(RT-PI)接受永久性植入物的放射治疗。队列 2(RT-TE)接受 TE 的放射治疗。分析 IF 率、不良事件和生活质量。随访/放疗后评估与交换手术后 3-10 周的基线/放疗前评估进行比较。一个亚组进行了一系列磁共振成像(MRI)检查,以探讨 MRI 检测到的变化与包膜挛缩之间的关系,包膜挛缩是放疗的已知不良影响。
2014 年 6 月至 2017 年 3 月,共纳入 119 名女性。队列 1 包括 45 名患者,队列 2 包括 74 名患者。在 100 名可评估参与者中,25 名在研究期间发生 IF。队列 1 和队列 2 中分别有 8/42(19%)和 17/58(29%)发生 IF。在 IF 中,大多数是由于包膜挛缩(13)、感染(7)、暴露(3)和其他原因(2)。在纵向 MRI 图像中观察到的形态学特征与 Baker 3 至 4 级挛缩的发展有关。
接受强度调制放疗的重建乳腺癌患者的 IF 率与传统的 3 维适形方法相似,但并未改善。MRI 特征显示出预测包膜挛缩的潜力,但需要在更大的研究中验证。